Paracetamol (acetaminophen): A familiar drug with an unexplained mechanism of action

References

• Von Mering J. Beiräge zur Kenntniss der Antipyretica. Therap. Monatsch.1893;7:558–577.
   Google Scholar
• Brodie BB, Axelrod J. The fate of acetophenetidin (phenacetin) in man and methods for the estimation of acetophenetidin and its metabolites in biological material. J Pharmacology Exp Ther.1949;97:58–67.
   PubMed Web of Science ®Google Scholar
• Schrör K. Aspirin and Reye syndrome: a review of the evidence. Paediatr Drugs. 2007;9(3):195–204.
   PubMedGoogle Scholar
• Prescott LF. Paracetamol: past, present and future. Am J Ther. 2000;7:143–147.
   PubMed Web of Science ®Google Scholar
• Hider-Mlynarz K, Cavalié P, Maison P. Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe. Br J Clin Pharmacol. 2018;84(6):1324–1334.
   PubMed Web of Science ®Google Scholar
• Wober C, Wober-Bingol C. Clinical management of young patients presenting with headache. Funct Neurol. 2000;15(3): 89–105. Suppl.
   PubMed Web of Science ®Google Scholar
• Woo WW, Man SY, Lam PK, et al. Randomized double-blind trial comparing oral paracetamol and oral nonsteroidal anti-inflammatory drugs for treating pain after musculoskeletal injury. Ann Emerg Med. 2005;46(4):352–361.
   PubMed Web of Science ®Google Scholar
• Pendergrass PB, Scott JN, Ream LJ, et al. Effect of small doses of aspirin and acetaminophen on total menstrual loss and pain of cramps and headache. Gynecol Obstet Invest. 1985;19(1):32–37.
   PubMed Web of Science ®Google Scholar
• Hochberg MC, Dougados M. Pharmacological therapy of osteoarthritis. Best Pract Res Clin Rheumatol. 2001;15(4):583–593.
   PubMed Web of Science ®Google Scholar
• Porter RW, Ralston SH. Pharmacological management of back pain syndromes. Drugs. 1994;48(2):189–198.
   PubMed Web of Science ®Google Scholar
• Dionne RA, Campbell RA, Cooper SA, et al. Suppression of postoperative pain by preoperative administration of ibuprofen in comparison to placebo, acetaminophen, and acetaminophen plus codeine. J Clin Pharmacol. 1983;23:37–43.
   PubMed Web of Science ®Google Scholar
• Haglund B, Von Bültzingslöwen I. Combining paracetamol with a selective cyclooxygenase‐2 inhibitor for acute pain relief after third molar surgery: a randomized, double‐blind, placebo‐controlled study. Eur J Oral Sci. 2006;114(4):293–301.
   PubMed Web of Science ®Google Scholar
• Dahl V, Raeder JC. Non-opioid postoperative analgesia. Acta Anaesthesiol. Scand. 2000;44:1191–1203.
   Google Scholar
• HKH L, SM T, FL L. A randomised control trial comparing the efficacy of tramadol and paracetamol against ketorolac and paracetamol in the management of musculoskeletal pain in the emergency department.J Emerg Crit Care Med. 2008;15(1):5–11.
   Google Scholar
• Moore RA, et al. Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen/paracetamol combinations after third molar extraction. Pain. 2011;152(5):982–989.
   PubMed Web of Science ®Google Scholar
• Flower RJ, Vane JR. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature. 1972;240:410–411.
   PubMed Web of Science ®Google Scholar
• Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature New Biol.1971;231:232–235.
   PubMedGoogle Scholar
• Feldberg W, Gupta KP, Milton AS, et al. Effect of bacterial pyrogen and antipyretics on prostaglandin activity in cerebrospinal fluid of unanaesthetised cats. BrJ Pharmacol. 1972;46: 550P-551P.
   Web of Science ®Google Scholar
• Yaksh TL, Malmberg AB. Spinal actions of NSAIDs in blocking spinally mediated hyperalgesia: the role of cyclooxygenase products. Agents Actions. 1993;41:89–100.
   PubMedGoogle Scholar
• Malmberg AB, Yaksh TL. Capsaicin-evoked prostaglandin E2 release in spinal cord slices: relative effect of cyclooxygenase inhibitors. Eur J Pharmacol. 1994;271(2–3):293–299.
   PubMed Web of Science ®Google Scholar
• Muth-Selbach US, Tegeder I, Brune K, et al. Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation. Anesthesiology. 1999;91:231–239.
   PubMed Web of Science ®Google Scholar
• Ayoub SS, Botting RM, Goorha S, et al. Acetaminophen-induced hypothermia in mice is mediated by a prostaglandin endoperoxide synthase 1 gene-derived protein. Proc Natl Acad Sci U S A. 2004;101:11165–11169.
   PubMed Web of Science ®Google Scholar
• Ayoub SS, Colville-Nash PR, Willoughby DA, et al. The involvement of a cyclooxygenase 1 gene-derived protein in the antinociceptive action of paracetamol in mice. Eur J Pharmacol. 2006;538(1–3):57–65.
   PubMed Web of Science ®Google Scholar
• Derendorf H, Drehsen G, Rohdewald P. Cortical-evoked potentials and saliva levels as basis for the comparison of pure analgesics to analgesic combinations. Pharmacology. 1982;25(4):227–236.
   PubMed Web of Science ®Google Scholar
• Bromm B, Forth W, Richter E, et al. Effects of acetaminophen and antipyrine on non-inflammatory pain and EEG activity. Pain. 1992;50(2):213–221.
   PubMed Web of Science ®Google Scholar
• Pickering G, Kastler A, Macian N, et al. The brain signature of paracetamol in healthy volunteers: a double-blind randomized trial. Drug Des Devel Ther. 2015;9:3853.
   PubMed Web of Science ®Google Scholar
• Shetty N1, AK P, SV G, et al. Comparison of the effects of ibuprofen and acetaminophen on PGE2 levels in the GCF during orthodontic tooth movement: a human study. Prog Orthod. 2013;14:6.
   PubMedGoogle Scholar
• Seppälä E, Laitinen O, Vapaatalo H. Comparative study on the effects of acetylsalicylic acid, indomethacin and paracetamol on metabolites of arachidonic acid in plasma, serum and urine in man. Int J Clin Pharmacol Res. 1983;3(4):265–269.
   PubMedGoogle Scholar
• ClissoldS P. Paracetamol and phenacetin. Drugs. 1986;32(4): 46–59. Suppl.
   PubMedGoogle Scholar
• Gwilt JR, Robertson A, Goldman L, et al. The absorption characteristics of paracetamol in man. J. Pharm Pharmacol.1963;15:445.
   PubMed Web of Science ®Google Scholar
• Langford RA, Hogg M, Bjorksten AR, et al. Comparative plasma and cerebrospinal fluid pharmacokinetics of paracetamol after intravenous and oral administration. Anesth Analg. 2016;123(3):610–615.
   PubMed Web of Science ®Google Scholar
• Appleton I. Non-steroidal anti-inflammatory drugs and pain. In: The pharmacology of pain. Berlin, Heidelberg: Springer; 1997. p. . 43–60.
   Google Scholar
• Mitchell JA, Akarasereenont P, Thiemermann C, et al. Selectivity of non-steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. proc. Natl. Acad. Sci. U S A.1993;90:11693–11697.
   PubMed Web of Science ®Google Scholar
• Botting RM. Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis. 2000;31(5): S202‐S210. Suppl.
   PubMedGoogle Scholar
• Willoughby DA, Moore AR, Colville-Nash PRCOX-1. COX-2, and COX-3 and the future treatment of chronic inflammatory disease. Lancet. 2000;355(9204):646‐648.
   PubMed Web of Science ®Google Scholar
• Chandrasekharan NV, Dai H, Roos KL, et al. a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure and expression. Proc Natl Acad Sci U S A. 2002;99:13926–13931.
   PubMed Web of Science ®Google Scholar
• Reinauer C, Censarek P, Kaber G, et al. Expression and translation of the COX-1b gene in human cells–no evidence of generation of COX-1b protein. Biol Chem. 2013;394(6):753–760.
   PubMed Web of Science ®Google Scholar
• Li S, Dou W, Tang Y, et al. Acetaminophen: antipyretic or hypothermic in mice? In either case, PGHS-1b (COX-3) is irrelevant. Prostaglandins Other Lipid Mediat. 2008;85(3–4):89–99.
   PubMed Web of Science ®Google Scholar
• Kis B, Snipes JA, Gaspar T, et al. Cloning of cyclooxygenase-1b (putative COX-3) in mouse. Inflamm Res. 2006;55(7):274–278.
   PubMed Web of Science ®Google Scholar
• Snipes JA, Kis B, Shelness GS, et al. Cloning and characterization of cyclooxygenase-1b (putative cyclooxygenase-3) in rat. J Pharmacol Exp Ther.2005;313(2):668–676.
   PubMed Web of Science ®Google Scholar
• Schwab JM, Beiter T, Linder JU, et al. COX-3-a virtual pain target in humans. Faseb J. 2003;17:2174–2175.
   PubMed Web of Science ®Google Scholar
• Qin N, Zhang SP, Reitz TL, et al. Cloning, expression, and functional characterization of human cyclooxygenase-1 splicing variants: evidence for intron 1 retention. J Pharmacol Exp Ther.2005;315(3):1298–1305.
   PubMed Web of Science ®Google Scholar
• Ayoub SS, Yazid S, Flower RJ. Increased susceptibility of annexin‐A1 null mice to nociceptive pain is indicative of a spinal antinociceptive action of annexin‐A1. Br J Pharmacol. 2008;154(5):1135–1142.
   PubMed Web of Science ®Google Scholar
• Ayoub SS, Wood EG, Hassan SU, et al. Cyclooxygenase expression and prostaglandin levels in central nervous system tissues during the course of chronic relapsing experimental autoimmune encephalomyelitis (EAE). Inflamm Res. 2011;60(10):919.
   PubMed Web of Science ®Google Scholar
• Ayoub SS, Botting RM. Iloprost-induced nociception: determination of the site of anti-nociceptive action of cyclooxygenase inhibitors and the involvement of cyclooxygenase products in central mechanisms of nociception. In: Ayoub SS, Flower RJ, Seed M, editors. Cyclooxygenases. US: Humana Press; 2010. p. 207–221.
   Google Scholar
• Ku EC, Wasvary JM, Cash WD. Diclofenac sodium (GP 45840, Voltaren), a potent inhibitor of prostaglandin synthetase. Biochem Pharmacol. 1975;24(5):641–643.
   PubMed Web of Science ®Google Scholar
• Tonussi CR, Ferreira SH. Mechanism of diclofenac analgesia: direct blockade of inflammatory sensitisation. Eur J Pharmacol. 1994;14(2–3):73–179.
   Google Scholar
• Gyires K, Knoll J. Inflammation and writhing syndrome inducing effect of PGE1, PGE2 and the inhibition of these actions. Pol J Pharmacol Pharm. 1975;27:257–264.
   PubMedGoogle Scholar
• Murata T, Ushikubi F, Matsuoka T, et al. Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature. 1997;388:678–682.
   PubMed Web of Science ®Google Scholar
• Horiguchi S, Ueno R, Hyodo M, et al. Alterations in nociception after intracisternal administration of prostaglandin D2, E2, or F2α to conscious mice. Eur J Pharmacol. 1986;122:173–179.
   PubMed Web of Science ®Google Scholar
• Hinz B, Cheremina O, Brune K. Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. Faseb J. 2007;22:383–390.
   PubMed Web of Science ®Google Scholar
• Sciulli MG, Seta F, Tacconelli S, et al. Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells. Br J Pharmacol. 2003;138(4):634–641.
   PubMed Web of Science ®Google Scholar
• Solomon DH. Selective cyclooxygenase 2 inhibitors and cardiovascular events. Arthritis Rheum. 2005;52(7):1968–1978.
   PubMedGoogle Scholar
• Ott E, Nussmeier NA, Duke PC, et al. The multicenter study of perioperative ischemia (McSPI) research group, and the ischemia research and education foundation (IREF) Investigators. efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2003;125:1481–1492.
   PubMed Web of Science ®Google Scholar
• Bombardier C, Laine L, Reicin A, et al. The VIGOR study group. VIGOR study group: comparison of upper gastrointestinal toxicity of rofecoxiband naproxen in patients with rheumatoid arthritis. N Engl J Med. 2000;343:1520–1528.
   PubMed Web of Science ®Google Scholar
• Roberts E, Nunes VD, Buckner S, et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016;75(3):552–559.
   PubMed Web of Science ®Google Scholar
• Graham GG, IG R, Day RO. Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol). Curr Pharm Des. 2002;8(12):1063–1075.
   PubMed Web of Science ®Google Scholar
• Skjelbred P, Løkken P. Paracetamol versus placebo: effects on post-operative course. Eur J Clin Pharmacol. 1979;15(1):27–33.
   PubMed Web of Science ®Google Scholar
• Bjørnsson GA, Haanaes HR, Skoglund LA. A randomized, double‐blind crossover trial of paracetamol 1000 mg four times daily vs ibuprofen 600 mg: effect on swelling and other postoperative events after third molar surgery. Br J Clin Pharmacol. 2003;55(4):405–412.
   PubMed Web of Science ®Google Scholar
• Boardman PL, Hart FD. Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis. BMJ. 1967;4(5574):264.
   PubMedGoogle Scholar
• Ring EF, Collins AJ, Bacon PA, et al. 1974. Quantitation of thermography in arthritis using multi-isothermal analysis. II. Effect of nonsteroidal anti-inflammatory therapy on the thermographic index. Ann Rheum Dis. 1974;33(4):353.
   PubMed Web of Science ®Google Scholar
• Seppälä E, Nissilä M, Isomäki H, et al. Comparison of the effects of different anti-inflammatory drugs on synovial fluid prostanoid concentrations in patients with rheumatoid arthritis. Clin Rheumatol. 1985;4(3):315.
   PubMed Web of Science ®Google Scholar
• Moore PK, Marshall M. Nitric oxide releasing acetaminophen (introacetaminophen). Dig Liver Dis. 2003;35(2): S49–S60. Suppl.
   PubMedGoogle Scholar
• Ballou LR, Botting RM, Goorha S, et al. Nociception in cyclooxygenase isoenzyme-deficient mice. Proc Natl Acad Sci U S A. 2000;97:10272–10276.
   PubMed Web of Science ®Google Scholar
• Hanel AM, Lands WE. Modification of anti-inflammatory drug effectiveness by ambient lipid peroxides. Biochem Pharmacol. 1982;31:3307–3311.
   PubMed Web of Science ®Google Scholar
• Marnett LJ. Cyclooxygenase mechanisms. Curr Opin Chem Biol. 2000;4(5):545–552.
   PubMed Web of Science ®Google Scholar
• Boutaud O, Aronoff DM, Richardson JH, et al. Determinants of the cellular specificity of acetaminophen as an inhibitor of prostaglandin H(2) synthases. Proc Natl Acad Sci U S A. 2002;99:7130–7135.
   PubMed Web of Science ®Google Scholar
• Ouellet M, Percival MD. Mechanism of acetaminophen inhibition of cyclooxygenase isoforms. Arch Biochem Biophys. 2001;387:273–280.
   PubMed Web of Science ®Google Scholar
• Lucas R, Warner TD, Vojnovic I, et al. Cellular mechanisms of acetaminophen: role of cyclo-oxygenase. Faseb J. 2005;19:635–637.
   PubMed Web of Science ®Google Scholar
• Schildknecht S, Daiber A, Ghisla S, et al. Acetaminophen inhibits prostanoid synthesis by scavenging the PGHS-activator peroxynitrite. Faseb J. 2008;22:215–224.
   PubMed Web of Science ®Google Scholar
• Ayoub SS, Joshi A, Chol M, et al. Inhibition of the diclofenac‐induced cyclooxygenase‐2 activity by paracetamol in cultured macrophages is not related to the intracellular lipid hydroperoxide tone. Fundam Clin Pharmacol. 2011;25(2):186–190.
   PubMed Web of Science ®Google Scholar
• Pickering G, Loriot MA, Libert F, et al. Analgesic effect of paracetamol in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther. 2006;79:371–378.
   PubMed Web of Science ®Google Scholar
• Pickering G, Estève V, Loriot MA, et al. Paracetamol reinforces descending inhibitory pain pathways. Clin Pharmacol Ther. 2008;84:47–51.
   PubMed Web of Science ®Google Scholar
• Alloui A, Pelissier T, Dubray C, et al. Tropisetron inhibits the antinociceptive effect of intrathecally administered paracetamol and serotonin. Fundam Clin Pharmacol. 1996;10:406–407.
   PubMed Web of Science ®Google Scholar
• Girard P, Pansart Y, M-C C, et al. Modulation of paracetamol and nefopam antinociception by serotonin 5-HT3 receptor antagonists in mice. Pharmacology. 2009;83:243–246.
   PubMed Web of Science ®Google Scholar
• Yogita SK, Peeyush B, Aditi P. Effect of drugs modulating serotonergic system on the analgesic action of paracetamol in mice. Indian J Pharmacol. 2016;48(3):281–285.
   PubMed Web of Science ®Google Scholar
• Roca-Vinardell A, Berrocoso E, Llorca-Torralba M, et al. Involvement of 5-HT1A/1B receptors in the antinociceptive effect of paracetamol in the rat formalin test. Neurobiol Pain. 2018;3:15–21.
   PubMedGoogle Scholar
• Bonnefont J, Chapuy E, Clottes E, et al. Spinal 5-HT1A receptors differentially influence nociceptive processing according to the nature of the noxious stimulus in rats: effect of WAY-100635 on the antinociceptive activities of paracetamol, venlafaxine and 5-HT. Pain. 2005;114(3):482–490.
   PubMed Web of Science ®Google Scholar
• Pelissier T, Alloui A, Caussade F, et al. Paracetamol exerts a spinal antinociceptive effect involving an indirect interaction with 5-hydroxytryptamine3-receptors: in vivo and in vitro evidence. J Pharmacol Exp Ther. 1996;278:8–14
   PubMed Web of Science ®Google Scholar
• Alloui A, Chassaing C, Schmidt J, et al. Paracetamol exerts a spinal, tropisetron-reversible, antinociceptive effect in an inflammatory pain model in rats. Eur J Pharmacol. 2002;443(1–3):71–77.
   PubMed Web of Science ®Google Scholar
• Dogrul A, Seyrek M, AkgulEO, et al. Systemic paracetamol-induced analgesic and antihyperalgesic effects through activation of descending serotonergic pathways involving spinal 5-HT7 receptors. Eur J Pharmacol. 2012;677(1–3):93–101.
   PubMed Web of Science ®Google Scholar
• Liu J, ReidA R, Sawynok J. Antinociception by systemically-administered acetaminophen (paracetamol) involves spinal serotonin 5-HT7 and adenosine A1 receptors, as well as peripheral adenosine A1 receptors. Neurosci Lett. 2013;536:64–68.
   PubMed Web of Science ®Google Scholar
• Pini LA, Sandrini M, Vitale G. The antinociceptive action of paracetamol is associated with changes in the serotonergic system in the rat brain. Eur J Pharmacol. 1996;308(1):31–40.
   PubMed Web of Science ®Google Scholar
• Raffa RB, Codd EE. Lack of binding of acetaminophen to 5-HT receptor or uptake sites (or eleven other binding/uptake assays). Life Sci. 1996;59(2): PL37-PL40.
   PubMed Web of Science ®Google Scholar
• Högestätt ED, Jönsson BA, Ermund A, et al. Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system. J Biol Chem. 2005;280(36):31405‐31412.
   Web of Science ®Google Scholar
• Costa B, Siniscalco D, Trovato A, et al. AM404, an inhibitor of anandamide uptake, prevents pain behaviour and modulates cytokine and apoptotic pathways in a rat model of neuropathic pain. Br J Pharmacol. 2006;148(7):1022–1032.
   PubMed Web of Science ®Google Scholar
• Barrière DA, Mallet C, Blomgren A, et al. Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain. PLoS One. 2013;8(8):e70690.
   PubMed Web of Science ®Google Scholar
• Mallet C, Barrière DA, Ermund A, et al. TRPV1 in brain is involved in acetaminophen-induced antinociception. PLoS One. 2010;5(9):e12748.
   PubMed Web of Science ®Google Scholar
• Soukupová M, Palazzo E, De Chiaro M, et al. Effects of URB597, an inhibitor of fatty acid amide hydrolase (FAAH), on analgesic activity of paracetamol. Neuro Endocrinol Lett. 2010;31(4):507‐511.
   PubMed Web of Science ®Google Scholar
• Ottani A, Leone S, Sandrini M, et al. The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors. Eur J Pharmacol. 2006;531(1–3):280‐281.
   PubMed Web of Science ®Google Scholar
• Kathuria FD, MercierR S, Li C, et al. Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172. Proc Natl Acad Sci U S A. 2004;101(23):8756–8761.
   PubMed Web of Science ®Google Scholar
• Dalmann R, Daulhac L, Antri M, et al. Supra-spinal FAAH is required for the analgesic action of paracetamol in an inflammatory context. Neuropharmacology. 2015;91:63‐70.
   PubMed Web of Science ®Google Scholar
• Barrière DA, Boumezbeur F, Dalman R, et al. Acetaminophen, a centrally‐acting analgesic involving the periaqueductal grey. Br J Pharmacol. 2020;77(8):1773–1792.
   Google Scholar
• Mallet C, Daulhac L, Bonnefont J, et al. Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain. 2008;139(1):190‐200.
   PubMed Web of Science ®Google Scholar
• Ruggieri V, Vitale G, PiniL A, et al. Differential involvement of opioidergic and serotonergic systems in the antinociceptive activity of N-arachidonoyl-phenolamine (AM404) in the rat: comparison with paracetamol. Naunyn Schmiedebergs Arch Pharmacol. 2008;377(3):219‐229.
   Web of Science ®Google Scholar
• Stueber T, Meyer S, Jangra A, et al. Activation of the capsaicin-receptor TRPV1 by the acetaminophen metabolite N-arachidonoylaminophenol results in cytotoxicity. Life Sci. 2018;194:67–74.
   PubMed Web of Science ®Google Scholar
• Pickering G, Creveaux I, Macian N, et al. Paracetamol and pain modulation by TRPV1, UGT2B15, SULT1A1 genotypes: a randomized clinical trial in healthy volunteers. Pain Med. 2020;21(4):661–669.
   PubMed Web of Science ®Google Scholar
• Zygmunt PM, Chuang -H-H, Movahed P, et al. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol. 2000;396(1):39–42.
   PubMed Web of Science ®Google Scholar
• Liu B, Fan L, Balakrishna S, et al. TRPM8 is the principal mediator of menthol-induced analgesia of acute and inflammatory pain. Pain. 2013 Oct;154(10):2169–2177.
   PubMed Web of Science ®Google Scholar
• Ayoub SS, Pryce G, Seed MP, et al. Paracetamol-induced hypothermia is independent of cannabinoids and transient receptor potential vanilloid-1 and is not mediated by AM404. Drug Metab Dispos. 2011;39(9):1689–1695.
   PubMed Web of Science ®Google Scholar
• Sharma CV, Long JH, Shah S, et al. First evidence of the conversion of paracetamol to AM404 in human cerebrospinal fluid. J Pain Res. 2017;10:2703‐2709.
   PubMed Web of Science ®Google Scholar
• Beltramo M, Stella N, Calignano A, et al. Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science. 1997;277(5329):1094–1097.
   PubMed Web of Science ®Google Scholar
• Giuffrida A, Beltramo M, Piomelli D. Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology. J Pharmacol Exp Ther. 2001;298(1):7–14.
   PubMed Web of Science ®Google Scholar
• Fu J, Bottegoni G, Sasso O, et al. A catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nat Neurosci. 2012;15(1):64–69. .
   Web of Science ®Google Scholar
• Saliba SW, Marcotegui AR, Fortwängler E, et al. AM404, paracetamol metabolite, prevents prostaglandin synthesis in activated microglia by inhibiting COX activity. J Neuroinflammation. 2017 Dec 13;14(1):246. Erratum in: J Neuroinflammation. 2018 Feb 6;15(1):34
   PubMedGoogle Scholar
• Muramatsu S, Shiraishi S, Miyano K, et al. Metabolism of AM404 from acetaminophen at human therapeutic dosages in the rat brain. Anesth Pain Med. 2016;6(1):e32873. .
   PubMedGoogle Scholar
• Kerckhove N, Mallet C, François A, et al. Ca(v)3.2 calcium channels: the key protagonist in the supraspinal effect of paracetamol. Pain. 2014;155(4):764–772.
   PubMed Web of Science ®Google Scholar
• Ray S, Salzer I, Kronschläger MT, et al. The paracetamol metabolite N-acetylp-benzoquinone imine reduces excitability in first- and second-order neurons of the pain pathway through actions on KV7 channels. Pain. 2019;160(4):954–964.
   PubMed Web of Science ®Google Scholar
• Walson PD, Galletta G, Chomilo F, et al. Comparison of multidose ibuprofen and acetaminophen therapy in febrile children. Am J Dis Child. 1992;146(5):626–632.
   PubMedGoogle Scholar
• Prymula R, Siegrist CA, Chlibek R, et al. Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials. Lancet. 2009;374(9698):1339–1350.
   PubMed Web of Science ®Google Scholar
• Karbasi SA, Modares-Mosadegh M, Golestan M. Comparison of antipyretic effectiveness of equal doses of rectal and oral acetaminophen in children. 2010;86(3):228–232. Journal De Pediatria.
   Google Scholar
• Li S, L R B, Morham SG, et al. Cyclooxygenase-2 mediates the febrile response of mice to interleukin-1β. Brain Res. 2001;910(1–2):163–173.
   PubMed Web of Science ®Google Scholar
• Harden LM, Du Plessis I, Poole S, et al. Interleukin (IL)-6 and IL-1β act synergistically within the brain to induce sickness behavior and fever in rats. Brain Behav Immun. 2008;22(6):838–849.
   PubMed Web of Science ®Google Scholar
• Klir JJ, Roth J, Szelenyi Z, et al. 1993. Role of hypothalamic interleukin-6 and tumor necrosis factor-alpha in LPS fever in rat. Am J Physiol Regul Integr Comp Physiol. 1993;265(3):R512–R517.
   Google Scholar
• Cao C, Matsumura K, Yamagata K, et al. Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1β: a possible site of prostaglandin synthesis responsible for fever. Brain Res. 1996;733(2):263–272.
   PubMed Web of Science ®Google Scholar
• Matsumura K, Cao C, Ozaki M, et al. Brain endothelial cells express cyclooxygenase-2 during lipopolysaccharide-induced fever: light and electron microscopic immunocytochemical studies. 1998;18(16):6279–6289.
   Google Scholar
• Cao C, Matsumura K, Ozaki M, et al. Lipopolysaccharide injected into the cerebral ventricle evokes fever through induction of cyclooxygenase-2 in brain endothelial cells Journal of Neurosci. 1999;19(2):716–725.
   Google Scholar
• Li S, Wang Y, Matsumura KRBL, et al. The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2−/−, but not in cyclooxygenase-1−/− mice. Brain Res. 1999;825(1–2):86–94.
   PubMed Web of Science ®Google Scholar
• Steiner AA, Rudaya AY, Robbins JR, et al. Expanding the febrigenic role of cyclooxygenase-2 to the previously overlooked responses. Am J Physiol Regul Integr Comp Physiol. 2005;289(5):R1253–R1257.
   PubMed Web of Science ®Google Scholar
• Nakamura K. Central circuitries for body temperature regulation and fever. Am J Physiol Regul Integr Comp Physiol. 2011;301(5):R1207–R1228.
   PubMed Web of Science ®Google Scholar
• Ushikubi F, Segi E, Sugimoto Y, et al. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP 3. Nature. 1998;395(6699):281–284.
   PubMed Web of Science ®Google Scholar
• Saha S, Engstrom L, Mackerlova L, et al. Impaired febrile responses to immune challenge in mice deficient in microsomal prostaglandin E synthase-1. Am J Physiol Regul Integr Comp Physiol. 2005;288(5):R1100–R1107.
   PubMed Web of Science ®Google Scholar
• Lazarus M, Yoshida K, Coppari R, et al. EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses. Nat Neurosci. 200710(9):1131–1133.
   Google Scholar
• Taniguchi Y, Yokoyama K, Inui K, et al. Inhibition of brain cyclooxygenase-2 activity and the antipyretic action of nimesulide. Eur J Pharmacol. 1997;330(2–3):221–229.
   PubMed Web of Science ®Google Scholar
• Steiner AA, Li S, Llanos QJ, et al. Differential inhibition by nimesulide of the early and late phases of intravenous- and intracerebroventricular-LPS-induced fever in guinea pigs. Neuroimmunomodulation. 2001;9(5):263–275.
   PubMed Web of Science ®Google Scholar
• Feldberg W, Gupta KP. Pyrogen fever and prostaglandin‐like activity in cerebrospinal fluid. J Physiol. 1973;228(1):41–53.
   PubMed Web of Science ®Google Scholar
• Abe M, Oka T, Hori T, et al. Prostanoids in the preoptic hypothalamus mediate systemic lipopolysaccharide-induced hyperalgesia in rats. Brain Res. 2001;1:1–9.
   Google Scholar
• Li S, Dou W, Tang Y, et al. Acetaminophen: antipyretic or hypothermic in mice? In either case, PGHS-1b (COX-3) is irrelevant. Prostaglandins Other Lipid Mediat. 2008;85(3–4):89–99.
   PubMed Web of Science ®Google Scholar
• Ryseck RP, Raynoschek C, Macdonald-Bravo H, et al. Identification of an immediate early gene, pghs-B, whose protein product has prostaglandin synthase/cyclooxygenase activity. Cell Growth Differ. 1992;3:443–450.
   PubMedGoogle Scholar
• Engström RL, Wilhelms DB, Eskilsson A, et al. Acetaminophen reduces lipopolysaccharide-induced fever by inhibiting cyclooxygenase-2. Neuropharmacology. 2013;71:124–129.
   PubMed Web of Science ®Google Scholar
• Massey TE, Walker RM, McElligott TF, et al. Acetaminophen-induced hypothermia in mice: evidence for a central action of the parent compound. Toxicology. 1982;25(2–3):187–200.
   PubMed Web of Science ®Google Scholar
• Feldberg W, Gupta KP, Milton AS, et al. Effect of pyrogen and antipyretics on prostaglandin activity in cisternal c.s.f. of unanaesthetized cats. J Physiol. 1973;234:279–303.
   PubMed Web of Science ®Google Scholar
• Kanashiro A, Pessini AC, Machado RR, et al. Characterization and pharmacological evaluation of febrile response on zymosan-induced arthritis in rats. Am J Physiol Regul Integr Comp Physiol. 2009;296:R1631–R1640.
   PubMed Web of Science ®Google Scholar
• Mirrasekhian E, Nilsson JL, Shionoya K, et al. The antipyretic effect of paracetamol occurs independent of transient receptor potential ankyrin 1‐mediated hypothermia and is associated with prostaglandin inhibition in the brain. The FASEB J.2018;32(10):5751–5759.
   PubMed Web of Science ®Google Scholar
• Ayoub SS, Flower RJ. Loss of hypothermic and anti-pyretic action of paracetamol in cyclooxygenase-1 knockout mice is indicative of inhibition of cyclooxygenase-1 variant enzymes. Eur J Pharmacol. 2019;861:172609.
   PubMed Web of Science ®Google Scholar
• Crawford IL, Kennedy JI, Lipton JM, et al. Effects of central administration of probenecid on fevers produced by leukocytic pyrogen and PGE2 in the rabbit. J Physiol. 1979;287:519–533.
   PubMed Web of Science ®Google Scholar
• Masferrer JL, Zweifel BS, Manning PT, et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci U S A. 1994;91:3228–3232.
   PubMed Web of Science ®Google Scholar
• Smith CJ, Zhang Y, Koboldt CM, et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc Natl Acad Sci U S A. 1998;95:13313–13318.
   PubMed Web of Science ®Google Scholar
• Yalçin SS, Gümüş A, Yurdakök K. Prophylactic use of acetaminophen in children vaccinated with diphtheria-tetanus-pertussis. World J Pediatr. 2008;4:112–127.
   Web of Science ®Google Scholar
• Van Tittelboom T, Govaerts-Lepicard M. Hypothermia: an unusual side effect of paracetamol. Vet Hum Toxicol. 1989;31(1):57–59.
   PubMedGoogle Scholar
• Nabulsi M, Tamim H, Sabra R, et al. Equal antipyretic effectiveness of oral and rectal acetaminophen: a randomized controlled trial [ISRCTN11886401]. BMC Pediatr. 2005;5:35.
   PubMedGoogle Scholar
• Foster J, Mauger A, Thomasson K, et al. Effect of acetaminophen ingestion on thermoregulation of normothermic, non-febrile humans. Front Pharmacol. 2016;7:54.
   PubMed Web of Science ®Google Scholar
• Foster J, AR M, Govus A, et al. Acetaminophen (paracetamol) induces hypothermia during acute cold stress. Clin Drug Investig. 2017;37(11):1055–1065.
   PubMed Web of Science ®Google Scholar
• Dippel DWJ, Van Breda EJ, HMA VG, et al. Effect of paracetamol (acetaminophen) on body temperature in acute ischemic stroke: a double-blind, randomized phase II clinical trial. Stroke. 2001;32(7):1607–1612.
   PubMed Web of Science ®Google Scholar
• Dippel DWJ, Van Breda EJ, Van Der Worp HB, et al. Timing of the effect of acetaminophen on body temperature in patients with acute ischemic stroke. Neurology. 2003;61(5):677–679.
   PubMed Web of Science ®Google Scholar
• Oka T, Oka K, Saper CB. Contrasting effects of E type prostaglandin (EP) receptor agonists on core body temperature in rats. Brain Res. 2003;968:256–262.
   PubMed Web of Science ®Google Scholar
• Pryce G, Giovannoni G, Baker D. Mifepristone or inhibition of 11beta-hydroxylase activity potentiates the sedating effects of the cannabinoid receptor-1 agonist Delta(9)-tetrahydrocannabinol in mice. Neurosci Lett. 2003;341:164–166.
   PubMed Web of Science ®Google Scholar
• Varga A, SzabÓ ŃJ, McDougall A, et al. Effects of the novel TRPV1 receptor antagonist SB366791 in vitro and in vivo in the rat. Neurosci Lett. 2005;385:137–142.
   PubMed Web of Science ®Google Scholar
• Rawls SM, Ding Z, Cowan A. Role of TRPV1 and cannabinoid CB1 receptors in AM404-evoked hypothermia in rats. Pharmacol Biochem Behav. 2006;83:508–516.
   PubMed Web of Science ®Google Scholar
• Gentry C, Andersson DA, Bevan S. TRPA1 mediates the hypothermic action of acetaminophen. Sci Rep. 2015;5(1):1–8.
   Google Scholar
• Garami A, Shimansky YP, Rumbus Z, et al. Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: insights from mathematical modeling and meta-analysis. Pharmacol Ther. 2020 Apr;208:107474.
   PubMed Web of Science ®Google Scholar
• Gavva NR, Bannon AW, Hovland DNJ, et al. Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.J Pharmacol Exp Ther. 2007;323(1):128–137.
   PubMed Web of Science ®Google Scholar
• Corley G, Rawls SM. Opioid, cannabinoid CB1 and NOP receptors do not mediate APAP-induced hypothermia in rats. Pharmacol Biochem Behav. 2009;92(3):503–507.
   PubMed Web of Science ®Google Scholar
• Coupar IM, Taylor DA. Alteration in the level of endogenous hypothalamic prostaglandins induced by delta 9-tetrahydrocannabinol in the rat. Br J Pharmacol. 1982;76(1):115.
   PubMed Web of Science ®Google Scholar
• Bashir S, Elegunde B, Morgan WA. Inhibition of lipolysis: a novel explanation for the hypothermic actions of acetaminophen in non-febrile rodents. Biochem Pharmacol. 2020;172:113774.
   PubMed Web of Science ®Google Scholar
• Satinoff E. Salicylate: action on normal body temperature in rats. Science. 1972;176:532–533.
   PubMed Web of Science ®Google Scholar
• Fischer LJ, Green MD, Harman AW. Levels of acetaminophen and its metabolites in mouse tissues after a toxic dose. J Pharmacol Exp Ther.1981;219(2):281–286.
   PubMed Web of Science ®Google Scholar
• Orbach SM, Cassin ME, Ehrich MF, et al. Investigating acetaminophen hepatotoxicity in multi-cellular organotypic liver models. Toxicol in Vitro. 2017;42:10–20.
   PubMed Web of Science ®Google Scholar
• Erman A, Schwartzman M, Raz A. Indomethacin but not aspirin inhibits basal and stimulated lipolysis in rabbit kidney. Prostaglandins. 1980;20(4):689–702.
   PubMedGoogle Scholar
• Vázquez-Meza H, De Piña MZ, Pardo JP, et al. Non-steroidal anti-inflammatory drugs activate NADPH oxidase in adipocytes and raise the H2O2 pool to prevent cAMP-stimulated protein kinase a activation and inhibit lipolysis. BMC Biochem. 2013;14(1):13.
   PubMedGoogle Scholar
• Clark WG, Alderdice MT. Inhibition of leukocytic pyrogen-induced fever by intracerebroventricular administration of salicylate and acetaminophen in the cat. Proc Soc Exp Biol Med. 1972;140(2):399–403.
   PubMed Web of Science ®Google Scholar
• Sproule BA, BustoU E, Buckle C, et al. The use of non‐prescription sleep products in the elderly. Int J Geriatr Psychiatry. 1999;14(10):851–857.
   PubMed Web of Science ®Google Scholar
• Murphy PJ, Badia P, Myers BL, et al. Nonsteroidal anti-inflammatory drugs affect normal sleep patterns in humans. Physiol Behav. 1994;55(6):1063–1066.
   PubMed Web of Science ®Google Scholar
• Baker FC, Driver HS, Paiker J, et al. Acetaminophen does not affect 24-h body temperature or sleep in the luteal phase of the menstrual cycle. J Appl Physiol. 2002;92(4):1684–1691.
   PubMed Web of Science ®Google Scholar
• Van De Glind EM, Hooft L, Tulner LR, et al. Acetaminophen for self-reported sleep problems in an elderly population (ASLEEP): a randomized double-blind placebo-controlled trial. Int J Geriatr Psychiatry. 2016;31(8):955–957.
   PubMed Web of Science ®Google Scholar
• Matsumura H, Goh Y, Ueno R, et al. 1988. Awaking effect of PGE2 microinjected into the preoptic area of rats. Brain Res. 1988;444(2):265–272.
   PubMed Web of Science ®Google Scholar
• Hayaishi O. Molecular mechanisms of sleep‐wake regulation: roles of prostaglandins D2 and E2. Faseb J. 1991;5(11):2575–2581.
   PubMed Web of Science ®Google Scholar
• Matsumura H, Honda K, Choi WS, et al. Evidence that brain prostaglandin E2 is involved in physiological sleep-wake regulation in rats. Proc Natl Acad Sci. 1989;86(14):5666–5669.
   PubMed Web of Science ®Google Scholar
• Saper CB, Romanovsky AA, Scammell TE. Neural circuitry engaged by prostaglandins during the sickness syndrome. Nat Neurosci. 2012 Jul 26;15(8):1088–1095.
   PubMed Web of Science ®Google Scholar
• Tittarelli R, Pellegrini M, Scarpellini MG, et al. Hepatotoxicity of paracetamol and related fatalities. Eur Rev Med Pharmacol Sci. 2017;21(1): 95–101. Suppl.
   PubMed Web of Science ®Google Scholar
• Smilkstein MJ, Knapp GL, Kulig KW, et al. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985). N Engl J Med. 1988;319(24):1557–1562.
   PubMed Web of Science ®Google Scholar
• Day M. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. BMJ. 2020;368:m1086.
   PubMedGoogle Scholar
• Moore N, Carleton B, Blin P, et al. Does Ibuprofen Worsen COVID-19? Drug Saf. 2020;43:611–614.
   PubMed Web of Science ®Google Scholar
• Sridharan GK, Kotagiri R, Chandiramani VH, et al. COVID-19 and avoiding ibuprofen. How good is the evidence? Am J Ther. 2020;27(4):e400–e402.
   PubMed Web of Science ®Google Scholar
• Hawkins LC, Edwards JN, Dargan PI. Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom. Drug Saf. 2007;30(6):465–479.
   PubMed Web of Science ®Google Scholar
• Bateman DN. Pack size and paracetamol overdose: 16 years later. Clin Toxicol. 2014;52(8):821–823.
   Web of Science ®Google Scholar
• Shah AD, Wood DM, Dargan PI. Internet survey of home storage of paracetamol by individuals in the UK. QJM. 2013;106(3):253–259.
   PubMed Web of Science ®Google Scholar
• McNicholl BP. Toxicity awareness and unintended suicide in drug overdoses. Emerg Med J. 1992;9(2):214–219.
   Google Scholar
• Hawton K, Ware C, Mistry H, et al. Why patients choose paracetamol for self-poisoning and their knowledge of its dangers. BMJ. 1995;310(6973):164.
   PubMed Web of Science ®Google Scholar